Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
23.29
+0.78 (3.44%)
Nov 21, 2024, 3:29 PM EST - Market open
Surgery Partners Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 38.71, with a low estimate of 34 and a high estimate of 50. The average target predicts an increase of 66.24% from the current stock price of 23.29.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SGRY stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Buy | 5 | 5 | 4 | 4 | 4 | 3 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 7 | 7 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $49 → $35 | Buy | Maintains | $49 → $35 | +50.31% | Nov 20, 2024 |
| Macquarie | Macquarie | Buy Maintains $34 | Buy | Maintains | $34 | +46.02% | Nov 19, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | +46.02% | Nov 13, 2024 |
| Macquarie | Macquarie | Buy Maintains $35 | Buy | Maintains | $35 | +50.31% | Nov 4, 2024 |
| UBS | UBS | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +63.20% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
3.15B
from 2.74B
Increased by 14.72%
Revenue Next Year
3.45B
from 3.15B
Increased by 9.56%
EPS This Year
1.08
from -0.09
EPS Next Year
1.29
from 1.08
Increased by 19.23%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.3B | 3.6B | 4.0B | |
| Avg | 3.1B | 3.4B | 3.8B | |
| Low | 3.0B | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 19.1% | 14.5% | 15.9% | |
| Avg | 14.7% | 9.6% | 9.3% | |
| Low | 9.9% | 3.4% | 2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.34 | 1.67 | 1.89 | |
| Avg | 1.08 | 1.29 | 1.59 | |
| Low | 0.86 | 0.85 | 1.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 54.3% | 46.5% | |
| Avg | - | 19.2% | 23.2% | |
| Low | - | -21.1% | -11.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.